Skip to main content

SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets

Company announces name change to SRX Global in conjunction with transaction closing Company’s stock to remain trading on the NYSE American (“NYSE”) under ticker symbol “SRXH” NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”, or “SRX”) today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. (“EMJX”) and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc. The Company’s stock will remain trading on the NYSE under the ticker symbol “SRXH” and will continue to trade...

Continue reading

MT Højgaard Holding A/S: Enemærke & Petersen to modernise Solbakken in Odense

MT Højgaard Holding’s business unit Enemærke & Petersen will, through Civica’s strategic construction partnership LIVA, be responsible for a comprehensive refurbishment and modernisation of housing department Solbakken section 311 in Odense. The project is structured as a turnkey contract with a contract value of DKK 302 million and will commence in June 2026 with planned handover in mid-2029. Solbakken consists of 267 housing units in three blocks from the 1950s and 1960s with mixed housing types, including 54 courtyard houses. The project is being carried out through a master plan with support from the Danish Building Fund and includes, among other things, the replacement of roofs, gables, windows and doors, bathrooms, installations, ventilation and lifts. In addition, conversions and mergers of homes will be carried...

Continue reading

Primech Holdings Secures Approximately US$36.1 Million in New Social Services and Public Sector Integrated Facility Services Contracts

Five-Year Education Sector Engagement and Social Services Contract Deepen Primech’s Role in Singapore’s Public Infrastructure SINGAPORE, June 18, 2026 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), a leading technology-driven facility services provider serving public and private sectors across Singapore, today announced that its subsidiary, Primech A & P Pte. Ltd., has been awarded two new facility services contracts valued at a combined S$46.2 million (US$36.1 million), with terms extending up to five years. The awards mark Primech’s deepest push yet into mission-critical public infrastructure: a flagship five-year engagement covering a major public-sector education portfolio, and a parallel contract with a social service organization supporting individuals with diverse needs. Anchoring...

Continue reading

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patientsFindings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflowRECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New ZealandVALENCIA, Calif., June 18, 2026 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the first documented use of RECELL GO in the United Kingdom (U.K.) at the 2026 British Burn Association (BBA) Annual Meeting in Nottingham, U.K. The presentation,...

Continue reading

Navigator Gas Announces Signing of $205.8 Million Financing for Two Newbuild Vessels, Incorporating its First JOLCO Sale Leaseback

LONDON, June 18, 2026 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (“Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces today that certain of its subsidiaries have entered into financing arrangements to finance the construction and delivery of two newbuild gas carriers (the “Vessels”) currently under construction in China by Jiangnan Shipyard (Group) Co. Ltd. and China Shipbuilding Trading Co. Ltd. (jointly the “Shipyard”), pursuant to shipbuilding contracts entered into in 2024, as previously announced on November 20, 2024. Delivery of the Vessels is expected in 2027. To fund construction-stage obligations, the Company’s subsidiary, Navigator Gas L.L.C. (the “Borrower”), has entered into a secured pre-delivery term loan of up to $164,640,000...

Continue reading

Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update

Type A Meeting Scheduled with FDA to Potentially Clarify Path to GTx-104 NDA Resubmission Phase 3 STRIVE-ON Safety Trial Data Presented at Multiple Medical Conferences Company Continues Disciplined Pre-Commercial Planning in Anticipation of Potential FDA Approval of NDAResubmission for GTx-104 for the Treatment of Patients with aSAH PRINCETON, N.J., June 18, 2026 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aSAH patients, today announced the financial results and business highlights for the fiscal year ended March 31, 2026. “Since receipt of the U.S. Food and Drug Administration’s (FDA) Complete...

Continue reading

Glucose Health, Inc. (GLUC) Reports Surge in GlucoDown Sales Among two of the Largest Retailers in the National Drug Store Channel

Continued Sales Momentum in National Pharmacy Chains Drives Increase in YOY Revenues and Raises Growth Outlook For 2026GlucoDown® is the first nutritional beverage enriched with our special form of soluble fiber which, clinical data indicates, can reduce your body’s metabolism of dietary sugars. In this way, GlucoDown®’s special soluble fiber helps to moderate increases in blood glucose levels, especially after meals.Bentonville, ARKANSAS, June 18, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTCID:GLUC), the maker of GlucoDown®, a scientifically formulated blood sugar support beverage, today announced continued growth and increasing momentum within the national pharmacy channel as demand from two of the largest U.S. pharmacy chains strengthened during the second quarter of 2026.  The Company recently...

Continue reading

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

       Principal Investigator Kathleen N. Moore, M.D., a leading expert in advanced ovarian cancer, will present the posterTARPON SPRINGS, Fla., June 18, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor— today announced that it will present a Trial-in-Progress poster at the ESMO Gynaecological Cancers Congress 2026, held June 17–19 in Copenhagen, Denmark. The poster outlines the scientific background, study design, and clinical rationale for the Company’s ongoing Phase 2 trial evaluating stenoparib in patients with advanced platinum-resistant or platinum-ineligible ovarian cancer. The study builds directly on Allarity’s prior Phase 2 clinical experience, including...

Continue reading

WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology

WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology EPO-Granted Patent Embeds NFTs Directly into Secure Semiconductors,Creating an Immutable Chain of Provenance, Ownership, and Authenticity for WISe.ART’s Global Art Ecosystem Geneva, Switzerland – June 18, 2026 — WISeKey International Holding Ltd (SIX: WIHN; NASDAQ: WKEY) (“WISeKey”), a global leader in cybersecurity, digital identity and IoT, today announced that its subsidiary, WISe.ART, the trusted digital art marketplace has become the world’s first hardware-authenticated art platform while its other subsidiary SEALSQ Corp. (NASDAQ: LAES) (“SEALSQ”) that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products...

Continue reading

Allegro MicroSystems Appoints Brian White to its Board of Directors

MANCHESTER, N.H., June 18, 2026 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced the appointment of Brian C. White to Allegro’s Board of Directors (“Board”) as an independent director. Mr. White’s appointment was effective on June 17, 2026. Mr. White is an accomplished executive and board director with over 30 years of leadership experience in the semiconductor and high-technology industries. He brings extensive expertise in financial strategy, public-company governance, and corporate development, having served as Chief Financial Officer for several publicly traded semiconductor companies, including Ambarella, Inc., Maxim Integrated Products, Inc., and Integrated Device Technology, Inc. “Brian’s public-company CFO perspective, semiconductor industry experience and governance background make him a strong...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.